Skip to Content

G 392 (Montelukast sodium 10 mg (base))

Pill imprint G 392 has been identified as Montelukast sodium 10 mg (base).

Montelukast is used in the treatment of allergic rhinitis; asthma, maintenance; bronchospasm prophylaxis; copd; asthma and belongs to the drug class leukotriene modifiers. There is no proven risk in humans during pregnancy. Montelukast 10 mg (base) is not a controlled substance under the Controlled Substance Act (CSA).

Montelukast sodium 10 mg (base) G 392
Montelukast sodium 10 mg (base) G 392
Discount Card Promo
Montelukast sodium
G 392
10 mg (base)
Prescription only
Drug Class:
Leukotriene modifiers
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Glenmark Generics Inc., USA
National Drug Code (NDC):
Inactive Ingredients:
microcrystalline cellulose
lactose monohydrate
croscarmellose sodium
hydroxypropyl cellulose
magnesium stearate
hypromellose 2910 (15000 mPa.s)
titanium dioxide
ferric oxide yellow
ferric oxide red
carnauba wax

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.